XML 48 R37.htm IDEA: XBRL DOCUMENT
v3.20.2

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | 12 Months Ended
--- | --- | --- | ---
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | Dec. 31, 2019
Product Information [Line Items] |  |  |  |  |
Effective tax rate | 0.00% | 0.00% | (4.00%) | (2.00%) |
Veritone [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Investment in Veritone | $ 982 |  | $ 982 |  |
Measurement Input, Price Volatility [Member] | Embedded Derivative [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Assumptions used for derivatives |  |  | 32 percent |  |
Measurement Input, Price Volatility [Member] | Black Scholes Model [Member] | Series A Warrants [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Assumptions used for derivatives |  |  | 32 percent |  |
Measurement Input, Price Volatility [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Warrant Price 525 [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Assumptions used for derivatives |  |  | 32 percent |  |
Measurement Input, Price Volatility [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Warrant Price 365 [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Assumptions used for derivatives |  |  | 51 percent |  |
Measurement Input, Risk Free Interest Rate [Member] | Embedded Derivative [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Assumptions used for derivatives |  |  | 0.47 percent |  |
Measurement Input, Risk Free Interest Rate [Member] | Black Scholes Model [Member] | Series A Warrants [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Assumptions used for derivatives |  |  | 0.47 percent |  |
Measurement Input, Risk Free Interest Rate [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Warrant Price 525 [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Assumptions used for derivatives |  |  | 0.48 percent |  |
Measurement Input, Risk Free Interest Rate [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Warrant Price 365 [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Assumptions used for derivatives |  |  | 0.13 percent |  |
Measurement Input, Expected Term [Member] | Black Scholes Model [Member] | Series A Warrants [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Assumptions used for derivatives |  |  | 7.04 years |  |
Measurement Input, Expected Term [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Warrant Price 525 [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Assumptions used for derivatives |  |  | 7.12 years |  |
Measurement Input, Expected Term [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Warrant Price 365 [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Assumptions used for derivatives |  |  | 1.9 years |  |
Measurement Input, Expected Dividend Rate [Member] | Embedded Derivative [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Assumptions used for derivatives |  |  | 0 percent |  |
Measurement Input, Expected Dividend Rate [Member] | Black Scholes Model [Member] | Series A Warrants [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Assumptions used for derivatives |  |  | 0 percent |  |
Measurement Input, Expected Dividend Rate [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Warrant Price 525 [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Assumptions used for derivatives |  |  | 0 percent |  |
Measurement Input, Expected Dividend Rate [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Warrant Price 365 [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Assumptions used for derivatives |  |  | 0 percent |  |
Measurement Input, Discount Rate [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Warrant Price 525 [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Assumptions used for derivatives |  |  | 10 percent |  |
Measurement Input, Discount Rate [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Warrant Price 365 [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Assumptions used for derivatives |  |  | 10 percent |  |
Measurement Input, Credit Spread [Member] | Embedded Derivative [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Assumptions used for derivatives |  |  | 21 percent |  |
Revenue Benchmark [Member] | One Licensee [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Concentration risk percentage | 98.00% | 52.00% | 75.00% | 46.00% |
Revenue Benchmark [Member] | One Licensee 2 [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Concentration risk percentage |  | 21.00% | 9.00% | 23.00% |
Revenue Benchmark [Member] | One Licensee 3 [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Concentration risk percentage |  | 12.00% | 8.00% | 14.00% |
Revenue Benchmark [Member] | One Licensee 4 [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Concentration risk percentage |  |  | 4.00% |  |
Revenue Benchmark [Member] | Foreign Licensee [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Concentration risk percentage | 0.10% | 75.00% | 5.00% | 38.00% |
Accounts Receivable [Member] | One Licensee [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Concentration risk percentage |  |  | 57.00% |  | 70.00%
Accounts Receivable [Member] | One Licensee 2 [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Concentration risk percentage |  |  | 25.00% |  | 17.00%
Accounts Receivable [Member] | One Licensee 3 [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Concentration risk percentage |  |  | 4.00% |  |
Accounts Receivable [Member] | One Licensee 4 [Member] |  |  |  |  |
Product Information [Line Items] |  |  |  |  |
Concentration risk percentage |  |  | 3.00% |  |

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Describes how an entity determines the fair values of its derivatives, including its valuation methodology and significant assumptions used. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -URI http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959 + Details
Name: | us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319 + Details
Name: | us-gaap_EffectiveIncomeTaxRateContinuingOperations
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Sum of the carrying amounts as of the balance sheet date of all investments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03.1(h)) -URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910 + Details
Name: | us-gaap_Investments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ProductInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=ACTG_VeritoneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DerivativeInstrumentRiskAxis=ACTG_EmbeddedDerivativeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=ACTG_BlackScholesModelMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DerivativeInstrumentRiskAxis=ACTG_SeriesAWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=ACTG_MonteCarloMethodMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DerivativeInstrumentRiskAxis=ACTG_SeriesBWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=ACTG_WarrantPrice525Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=ACTG_WarrantPrice365Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCreditSpreadMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=ACTG_OneLicenseeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=ACTG_OneLicensee2Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=ACTG_OneLicensee3Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=ACTG_OneLicensee4Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=ACTG_ForeignLicenseeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |